These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 434677)

  • 1. Primary pulmonary hypertension treated with oral phentolamine.
    Ruskin JN; Hutter AM
    Ann Intern Med; 1979 May; 90(5):772-4. PubMed ID: 434677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous phentolamine on hemodynamics and resting pulmonary gas exchange in man.
    Gould L; Reddy CV; Becker WH; Macklin EE
    Angiology; 1980 Feb; 31(2):120-5. PubMed ID: 7362073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of regitine haemodynamics of pulmonary circulation in pulmonary hypertension in man.
    Horzela T; Dubiel JP; Dubiel JS; Pyzik Z; Szczeklik J
    Acta Physiol Pol; 1974 May; 25(3):241-9. PubMed ID: 4842545
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of primary pulmonary hypertension with phentolamine].
    Heinrich U; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1983 Jan; 113(4):145-8. PubMed ID: 6828847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral hydralazine therapy for primary pulmonary hypertension.
    Rubin LJ; Peter RH
    N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic improvement following a single dose of oral phentolamine. Administration in patients with chronic low output cardiac failure.
    Schreiber R; Maier PT; Gunnar RM; Loeb HS
    Chest; 1979 Nov; 76(5):571-5. PubMed ID: 498831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phentolamine infusion in cor pulmonale due to chronic obstructive pulmonary disease.
    Van Mieghem W; De Backer G; De Wispelaere B; Billiet L; Cosemans J
    Acta Cardiol; 1978; 33(4):253-62. PubMed ID: 309265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE CIRCULATORY EFFECTS OF INTRAVENOUS PHENTOLAMINE IN MAN.
    TAYLOR SH; SUTHERLAND GR; MACKENZIE GJ; STAUNTON HP; DONALD KW
    Circulation; 1965 May; 31():741-54. PubMed ID: 14278066
    [No Abstract]   [Full Text] [Related]  

  • 9. Phentolamine: use in pulmonary edema. Preliminary report.
    Gould L; Zahir M; Shariff M; Giuliani M
    Jpn Heart J; 1970 Mar; 11(2):141-8. PubMed ID: 5310412
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of phentolamine in experimental hemorrhagic shock.
    Gould L; Ettinger S; Carmichael A; Lord P; Hofstra P
    Angiology; 1970 May; 21(5):330-5. PubMed ID: 5443090
    [No Abstract]   [Full Text] [Related]  

  • 11. [The therapeutic modification of the primary vascular form of chronic cor pulmonale and of continuing pulmonary hypertension after commissurotomy for mitral stenosis. A comparison with control of the pulmonary artery pressure].
    Degenring FH
    Z Kreislaufforsch; 1970 Oct; 59(10):912-23. PubMed ID: 4395191
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.
    Daoud FS; Reeves JT; Kelly DB
    Am J Cardiol; 1978 Nov; 42(5):817-22. PubMed ID: 707294
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effect of hydralazine in patients with primary pulmonary hypertension.
    Kronzon I; Cohen M; Winer HE
    JAMA; 1982 Jun; 247(22):3112-4. PubMed ID: 7077805
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Hermiller JB; Bambach D; Thompson MJ; Huss P; Fontana ME; Magorien RD; Unverferth DV; Leier CV
    Ann Intern Med; 1982 Oct; 97(4):480-9. PubMed ID: 7125407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of phentolamine in chronic obstructive pulmonary disease.
    Gould L; Zahir M; DeMartino A; Gomprecht RF
    Br Heart J; 1971 Jul; 33(4):445-50. PubMed ID: 5557456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency].
    Korewicki J; Rajecka A; Pogorzelska H; Madeja G
    Kardiol Pol; 1990; 33(6):365-74. PubMed ID: 2128094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise.
    Blumberg FC; Riegger GA; Pfeifer M
    Chest; 2002 May; 121(5):1566-71. PubMed ID: 12006445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.
    Majid PA; Meeran MK; Benaim ME; Sharma B; Taylor SH
    Br Heart J; 1974 Jun; 36(6):588-96. PubMed ID: 4850484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.